Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
This report contains market size and forecasts of Platelet-rich Plasma Therapy in Global, including the following market information:
Global Platelet-rich Plasma Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Platelet-rich Plasma Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pure PRP Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Platelet-rich Plasma Therapy include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics and Weigao, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Platelet-rich Plasma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Platelet-rich Plasma Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, by Type, 2021 (%)
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Global Platelet-rich Plasma Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, by Application, 2021 (%)
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Others
Global Platelet-rich Plasma Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Platelet-rich Plasma Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Platelet-rich Plasma Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics